EUVIMEDEUVIMED entdecken
Klinische Studie (Phase I)Multizentrische StudieVideo/Audio

Optogenetic Therapy for Restoring Aspects of Visual Function

José-Alain Sahel, Stefan Futterknecht iD, Isabelle Audo, Joseph N Martel, Shouyu Ling, Chloé Pagot, Angelo Arleo, Elise Boulanger-Scemama, Antonin Duret, Jean-Baptiste de Saint Aubert, Alexandre Delaux iD, Simona Degli Esposti und 8 weitere

New England Journal of Medicine · 08.10.2026 · 395 (14) · 1399-1408

DOI: 10.1056/nejmoa2602215 ↗

Kurz gefasst

Klinische Studie (Phase I) in der Zeitschrift New England Journal of Medicine, erschienen am 08.10.2026. Verfasst von José-Alain Sahel und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, University of Pittsburgh School of Medicine, Pittsburgh. Hauptthemen laut MEDLINE: Genetic Therapy, Optogenetics, Retinitis Pigmentosa, Rhodopsin. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 20 Literaturangaben. Gefördert von: GenSight Biologics.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Genetic TherapyOptogeneticsRetinitis PigmentosaRhodopsinAdultAgedFemaleHumansMaleMiddle AgedDependovirusGene Therapy AgentsGenetic VectorsIntravitreal InjectionsRetinal Ganglion CellsVisual AcuityTreatment Outcome

Substanzen

Rhodopsin

Autor:innen und Institutionen

  • Department of Ophthalmology, University of Pittsburgh School of Medicine, Pittsburgh.
  • Sorbonne Université, Institut National de la Santé et de la Recherche Médicale, Centre National de la Recherche Scientifique, Institut de la Vision, Paris.
  • L'Hôpital Fondation Adolphe de Rothschild, Paris.
  • Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts, Paris.
  • Institute of Molecular and Clinical Ophthalmology Basel, Basel, Switzerland.
  • University of Basel, Department of Ophthalmology, Basel, Switzerland.

ORCID-Profile: Stefan Futterknecht, Alexandre Delaux

Förderung

  • GenSight Biologics

Zitieren

APA

Sahel, J. A., Futterknecht, S., Audo, I., Martel, J. N., Ling, S., Pagot, C., Arleo, A., Boulanger-Scemama, E., Duret, A., de Saint Aubert, J. B., Delaux, A., Degli Esposti, S., Coen, C., de Montleau, C., Aravich, D., Smith, W., Hayem, C., Taiel, M., Behrmann, M., & Roska, B. (2026). Optogenetic Therapy for Restoring Aspects of Visual Function. New England Journal of Medicine, 395(14), 1399-1408. https://doi.org/10.1056/nejmoa2602215

Vancouver

Sahel JA, Futterknecht S, Audo I, Martel JN, Ling S, Pagot C, et al. Optogenetic Therapy for Restoring Aspects of Visual Function. New England Journal of Medicine. 2026;395(14):1399-1408. doi:10.1056/nejmoa2602215

BibTeX
@article{Sahel2026,
  author = {Sahel, José-Alain and Futterknecht, Stefan and Audo, Isabelle and Martel, Joseph N and Ling, Shouyu and Pagot, Chloé and Arleo, Angelo and Boulanger-Scemama, Elise and Duret, Antonin and de Saint Aubert, Jean-Baptiste and Delaux, Alexandre and Degli Esposti, Simona and Coen, Cécilia and de Montleau, Caroline and Aravich, Dana and Smith, William and Hayem, Cecile and Taiel, Magali and Behrmann, Marlene and Roska, Botond},
  title = {Optogenetic Therapy for Restoring Aspects of Visual Function},
  journal = {New England Journal of Medicine},
  year = {2026},
  volume = {395},
  number = {14},
  pages = {1399--1408},
  doi = {10.1056/nejmoa2602215}
}
Kostenlos starten →